According to the class action lawsuit, Bayer and Merial collectively sell approximately $2 billion in flea and tick products annually, including Bayer’s line of Advantage, Advantix, K9 Advantix and Advocate products, and Merial’s line of Frontline and Certifect products. These products are sold as treatments for dogs and cats suffering with fleas, ticks, adult flea eggs, larvae, mosquito, heartworm, ear mites and sarcoptic mange. While each one of individual products targets only a limited subset of the pet aliments, all of the products target fleas and their larvae.
The problem, the flea and tick product class action lawsuit states, is that Bayer and Merial make false and/or misleading claims about what these products do. These allegedly false advertising claims include that the products:
* are self-dispersing and cover the entire surface area of the dog or cat’s body when applied in a single limited spot;
* are effective for one month and require monthly application to continue to be effective;
* do not enter the blood stream of the pet and instead move across the pet’s skin to cover the pet; and
* are waterproof and remain effective following shampoo treatments, swimming, or after exposure to rain or sunlight.
The Bayer and Merial Flea and Tick Product Class Action Lawsuit is seeking to recover damages on behalf of all consumers who purchased the products, as well as an injunction barring Bayer and Merial from continuing to misrepresent what their flea and tick products can do.